CELF1 and non-small cell lung carcinoma: The results are the same in non-small-cell lung cancer, where the downregulation of CELF1 induces an increase in the protein levels of cyclin D1, BAD, BAX, Jun D, and E-cadherin, indicating a function for CELF1 in the EMT (epithelial to mesenchymal transition).